Product Information
- Gb3α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-1→O-ceramideCeramide trihexosides
- 71965-57-6
- Cd 77
- Ceramide trihexoside
- Ceramide, 1-O-(O-α-<span class="text-smallcaps">D</smallcap>-galactopyranosyl-(1→4)-O-β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)-β-<smallcap>D</span>-glucopyranosyl)-
- Fabry glycolipid
- Ganglioside G<sub>L3</sub>
- Ganglioside Gb<sub>3</sub>
- Gb<sub>3</sub>
- Gb<sub>3</sub>Cer
- See more synonyms
- Globo-N-triaosylceramide
- Globotriglycosylceramide
- Globotriosylceramide
- Shiga toxin receptor
- Trihexosylceramide
It is one of the few clusters of differentiation that is not a protein and structurally contains a galactose moiety linked α to lactosylceramide. Defects in the enzyme α-galactosidase lead to the buildup of globotriaosylceramide, causing Fabry's disease. The pharmaceutical drug migalastat enhances the function of α-galactosidase and is used to treat Fabry's. Globotriaosylceramide is also one of the targets of Shiga toxin, which is responsible for pathogenicity of enterohemorrhagic E. coli.
Chemical properties
Technical inquiry about: 3D-OG45939 Globotriaosylceramide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
